| Aktie | Ticker | 2025/Q2 | 2025/Q1 | ||
|---|---|---|---|---|---|
| Investment ($) | QoQ Veränd. ($) | Investment ($) | QoQ Veränd. ($) | ||
| 756.303.750 $ | -1.179.506.750 $ | 1.975.892.620 $ | +1.975.892.620 $ | ||
| BANK OF AMERICA CORP /DE/ | BAC | 340.075.000 $ | -791.010.750 $ | 1.131.085.750 $ | +1.131.085.750 $ |
| PFIZER INC | PFE | 36.360.000 $ | -199.302.000 $ | 235.662.000 $ | +235.662.000 $ |
| HUMANA INC | HUM | 73.344.000 $ | -118.491.000 $ | 191.835.000 $ | +191.835.000 $ |
| CVS HEALTH Corp | CVS | 72.429.000 $ | -80.008.500 $ | 152.437.500 $ | +152.437.500 $ |
| Viatris Inc | VTRS | 24.557.500 $ | -40.767.500 $ | 65.325.000 $ | +65.325.000 $ |
| Ascendis Pharma A/S | ASND | 43.150.000 $ | -11.401.000 $ | 54.551.000 $ | +54.551.000 $ |
| ICON PLC | ICLR | 43.635.000 $ | +43.635.000 $ | ||
| GSK plc | GSK | 38.400.000 $ | -340.000 $ | 38.740.000 $ | +38.740.000 $ |
| BIOMARIN PHARMACEUTICAL INC | BMRN | 32.982.000 $ | -2.363.000 $ | 35.345.000 $ | +35.345.000 $ |
| UNITEDHEALTH GROUP INC | UNH | 31.197.000 $ | +31.197.000 $ | ||
| IONIS PHARMACEUTICALS INC | IONS | 21.873.250 $ | +21.873.250 $ | ||
| MYRIAD GENETICS INC | MYGN | 10.620.000 $ | -10.224.500 $ | 20.844.500 $ | +20.844.500 $ |
| MoonLake Immunotherapeutics | MLTX | 17.229.870 $ | +17.229.870 $ | ||
| Inogen Inc | INGN | 6.854.250 $ | -97.500 $ | 6.951.750 $ | +6.951.750 $ |
| ORASURE TECHNOLOGIES INC | OSUR | 2.700.000 $ | -333.000 $ | 3.033.000 $ | +3.033.000 $ |
| GENMAB A/S | GMAB | 979.000 $ | +979.000 $ | ||
| 756.303.750 $ | -1.179.506.750 $ | 1.975.892.620 $ | +1.975.892.620 $ | ||
Erweiterte Einstellungen
×